Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Gynecol Oncol. 2008 Apr 18;110(1):49–55. doi: 10.1016/j.ygyno.2008.02.009

Table 3.

Median, min/max VEGF levels, and number (n) of patients.

Responders (CR+PR+SD) Non-responders (PD) p-value
Baseline plasma VEGF 105
16/198
(n=6)		 74
52/147
(n=4)		 0.75
Baseline urine VEGF 68
8/814
(n=7)		 227
29/355
(n=4)		 0.34
Urine VEGF change −10
−66/133
(n=5)		 19
−151/68
(n=3)		 0.65
Baseline VEGFR2 15990
6515/19860
(n=5)		 15770
14998/18320
(n=4)		 1.00
VEGFR2 change 2648
129/5393
(n=4)		 280
−3317/1874
(n=3)		 0.16